Apr 24 |
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
|
Apr 13 |
The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX)
|
Apr 9 |
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
|
Apr 5 |
Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March
|
Apr 5 |
Biodesix prices its 17.4M shares offering at $1.15 apiece
|
Apr 5 |
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
|
Mar 25 |
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
|
Mar 4 |
Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript
|
Mar 3 |
Biodesix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Mar 2 |
Q4 2023 Biodesix Inc Earnings Call
|